Treatment preferences and real-world outcomes for patients with complex lentigo maligna
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llae146 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Evelyn Tay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Changi General Hospital, Singapore. Hauptthemen laut MEDLINE: Hutchinson's Melanotic Freckle, Skin Neoplasms, Patient Preference. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
The recent review on lentigo maligna (LM) succinctly outlines treatment options for patients with LM. Our own retrospective real-world data regarding patient preferences and treatment outcomes may be instructive for dermatologists treating patients with LM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Changi General Hospital, Singapore.
- St John's Institute of Dermatology, London, UK.
ORCID-Profile: Faisal R Ali
Zitieren
APA
Tay, E., Ali, F. R., & Craythorne, E. (2024). Treatment preferences and real-world outcomes for patients with complex lentigo maligna. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae146
Vancouver
Tay E, Ali FR, Craythorne E. Treatment preferences and real-world outcomes for patients with complex lentigo maligna. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae146
BibTeX
@article{Tay2024,
author = {Tay, Evelyn and Ali, Faisal R and Craythorne, Emma},
title = {Treatment preferences and real-world outcomes for patients with complex lentigo maligna},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llae146}
}
EUVIMED